In Brief: LaserSight
This article was originally published in The Gray Sheet
LaserSight: Company will focus resources on its laser platform for refractive surgery after gaining approximately $13 mil. from the sale of two of their subsidiaries, MEC Health Care and LSI Acquisition, to Vision Twenty-One. The deal, announced Dec. 31, gives LaserSight $6.5 mil. paid in cash at closing and about $6.5 mil. paid in common stock of Vision Twenty-One. The company estimated after-tax gain of $1.5 mil. to $2 mil. from the transaction, which is subject to post-closing adjustments. MEC Health Care administers HMO and self-insured vision plans; LSI Acquisition is a practice management company that oversees the ophthalmic business known as the Northern New Jersey Eye Institute...
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.